4519
CHUGAI PHARMACEUTICAL CO.,LTD.
中外製薬
- Industry
- Pharmaceutical
- Market
- Prime
- Accounting standards
- IFRS
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Dec 2021
999,759
Dec 2022
1,259,946
Dec 2023
1,111,367
Dec 2024
1,170,611
Dec 2025
1,257,941
Operating profit(million JPY)
Dec 2021
421,897
Dec 2022
533,309
Dec 2023
439,174
Dec 2024
542,002
Dec 2025
598,833
Operating profit margin(%)
Dec 2021
42.2
Dec 2022
42.33
Dec 2023
39.52
Dec 2024
46.3
Dec 2025
47.6
Profit before tax(million JPY)
Dec 2021
419,385
Dec 2022
531,166
Dec 2023
443,821
Dec 2024
543,034
Dec 2025
597,807
Profit(million JPY)
Dec 2021
302,995
Dec 2022
374,429
Dec 2023
325,472
Dec 2024
387,317
Dec 2025
434,012
Total assets(million JPY)
Dec 2021
1,538,694
Dec 2022
1,869,758
Dec 2023
1,932,547
Dec 2024
2,208,373
Dec 2025
2,468,595
Cash and cash equivalents(million JPY)
Dec 2021
267,753
Dec 2022
222,169
Dec 2023
458,674
Dec 2024
540,202
Dec 2025
426,602
Cash flows from operating activities(million JPY)
Dec 2021
279,626
Dec 2022
244,112
Dec 2023
409,925
Dec 2024
447,600
Dec 2025
386,280
Cash flows from investing activities(million JPY)
Dec 2021
-118,927
Dec 2022
-145,994
Dec 2023
-37,290
Dec 2024
-227,365
Dec 2025
-201,273
Cash flows from financing activities(million JPY)
Dec 2021
-107,408
Dec 2022
-145,641
Dec 2023
-139,331
Dec 2024
-141,006
Dec 2025
-307,886
Return on equity(%)
Dec 2021
28
Dec 2022
28.7
Dec 2023
21.3
Dec 2024
22
Dec 2025
22.1
Equity ratio(%)
Dec 2021
77.2
Dec 2022
76.2
Dec 2023
84.1
Dec 2024
86.1
Dec 2025
82.1
Earnings per share(JPY per share)
Dec 2021
184.29
Dec 2022
227.64
Dec 2023
197.83
Dec 2024
235.39
Dec 2025
263.73
Net assets per share(JPY per share)
Dec 2021
722.5
Dec 2022
865.88
Dec 2023
988.01
Dec 2024
1,155.56
Dec 2025
1,230.91
Dividend per share(JPY per share)
Dec 2021
76
Dec 2022
78
Dec 2023
80
Dec 2024
98
Dec 2025
272
Payout ratio(%)
Dec 2021
41.24
Dec 2022
34.26
Dec 2023
40.44
Dec 2024
41.63
Dec 2025
103.14
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.